Enter your login e-mail to the account
Search
Search parameters
Search results
- Possibilities and tricks of vaccination in patients with cancer
MUDr. Juraj Chudej, PhD., Doc. MUDr. Miloš Jeseňák, PhD., MBA, Dott. Ric., MHA, MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD.
(5/2017, Interdisciplinary consilium ) - Acute leukemias – what should general practitioner know
MUDr. Juraj Chudej, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., Prof. MUDr. Ján Staško, PhD.
(3/2016, Review articles ) - Management of anemia in patients with Myelodysplastic Syndrome
MUDr. Eva Mikušková, MUDr. Tomáš Guman, PhD., MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár
(3-4/2014, Interdisciplinary consilium )
- Comprehensive management and systemic therapy of hepatocellular carcinoma
MUDr. Marína Kizeková, MUDr. Matej Hrnčár, PhD., MBA
(6/2024, Review articles ) - Polycytemia vera – how to treat further the patient after exhaustion of conventional therapy (hydroxyurea and interferon)
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, PhD., doc. MUDr. Juraj Sokol, PhD.
(S2/2020, Case reports ) - Ixazomib, lenalidomide, dexamethasone in the treatment of patients with relapsed and refractory multiple myeloma
doc. MUDr. Juraj Sokol, PhD., MUDr. Juraj Chudej, PhD., MUDr. František Nehaj, MUDr. Lenka Lisá, PhD., MUDr. Matej Hrnčár, PhD., Prof. MUDr. Ján Staško, PhD.
(3/2020, Review articles ) - Gastrointesintal stromal tumors – new possibilities in the strategy of treatment
MUDr. Matej Hrnčár, MUDr. Eva Pritzová
(1/2019, Main topic ) - Použitie rastových faktorov myelopoézy v profylaxii febrilnej neutropénie
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Ľubica Váleková, PhD., Prof. MUDr. Ján Staško, PhD.
(2/2018, Review articles ) - Primary treatment of metastatic prostate cancer
MUDr. Matej Hrnčár, MUDr. Marek Lafférs, MUDr. Jozef Breznický, MUDr. Ján Šulgan, MUDr. Juraj Sokol, PhD., PhD., MUDr. Juraj Chudej, PhD.
(5/2017, Review articles ) - Continuuing treatment of hepatocellular carcinoma with sorafenib after radiological progression – case report
MUDr. Eva Pritzová, MUDr. Matej Hrnčár
(2/2016, Original articles & case reports ) - The current status of biological therapy for relapsed/refractory classical hodgkin lymphoma – a case report
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(2/2015, Original articles & case reports ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Myelodysplastic syndrome – medicine made to measure
MUDr. Eva Mikušková, doc. MUDr. Ján Staško, PhD., MUDr. Juraj Chudej, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(6/2014, Spectrum )
- Thrombophilia and hepatocellular carcinoma
MUDr. Matej Hrnčár, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, PhD., MUDr. Dagmar Styková, prof. MUDr. Ján Staško, PhD., prof. MUDr. Peter Kubisz, DrSc.
(2/2017, Review articles ) - The prophylaxis of venous thromboembolism and metastatic breast cancer
prof. MUDr. Peter Kubisz, DrSc., MUDr. Juraj Chudej, PhD., MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(2/2016, Original articles & Case reports ) - Thrombosis and lymphoproliferative disorders
doc. MUDr. Ján Staško, PhD., prof. MUDr. Peter Kubisz, DrSc., MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(2/2015, Review articles )